Salmeterol Xinafoate
C25H37NO4·C11H8O3
603.75
1,3-Benzenedimethanol, 4-hydroxy-α1-[[[6-(4-phenylbut oxy)hexyl]amino]methyl]-, (±)-, 1-hydroxy-2-naphthalenecarboxylate (salt);
(±)-4-Hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-m-xylene-α,α′-diol 1-hydroxy-2-naphthoate (salt) [94749-08-3]
1,3-Benzenedimethanol, 4-hydroxy-α1-[[[6-(4-phenylbut oxy)hexyl]amino]methyl]-, (±)-, 1-hydroxy-2-naphthalenecarboxylate (salt);
(±)-4-Hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-m-xylene-α,α′-diol 1-hydroxy-2-naphthoate (salt) [94749-08-3]
DEFINITION
Salmeterol Xinafoate contains NLT 98.0% and NMT 102.0% of salmeterol xinafoate (C25H37NO4·C11H8O3), calculated on the water- and solvent-free basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Salmeterol Related Compound A RSUSP Salmeterol Related Compound B RS
USP Salmeterol Xinafoate RS